Synergistic Antinociception by the Cannabinoid Receptor Agonist Anandamide and the PPAR-α Receptor Agonist GW7647

European Journal of Pharmacology - Netherlands
doi 10.1016/j.ejphar.2007.03.007
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Central Antinociception Induced by Μ-Opioid Receptor Agonist Morphine, but Not Δ- Or Κ-, Is Mediated by Cannabinoid CB1receptor

British Journal of Pharmacology
Pharmacology
2009English

Cannabinoid Receptor Type 2 Agonist JWH-133 Deteriorates the Liver Toxicity Induced by Cypermethrin

Turkish Journal of Veterinary and Animal Sciences
Veterinary
2018English

Modification of Κ-Opioid Receptor Agonist-Induced Antinociception by Diabetes in the Mouse Brain and Spinal Cord

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2005English

Anandamide Transport Inhibition by the Vanilloid Agonist Olvanil

European Journal of Pharmacology
Pharmacology
1999English

Radioligand Thermostability Assessment of Agonist-Bound Human Type 2 Cannabinoid Receptor

Biophysical Journal
Biophysics
2019English

Prejunctional and Peripheral Effects of the Cannabinoid CB1 Receptor Inverse Agonist Rimonabant (SR 141716)

Naunyn-Schmiedeberg's Archives of Pharmacology
MedicinePharmacology
2008English

Modulation of Passive Avoidance in Mice by the 5-Ht1a Receptor Agonist Flesinoxan: Comparison With the Benzodiazepine Receptor Agonist Diazepam

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2002English

O-1057, a Potent Water-Soluble Cannabinoid Receptor Agonist With Antinociceptive Properties

British Journal of Pharmacology
Pharmacology
2000English

Analysis and Clinical Findings of Cases Positive for the Novel Synthetic Cannabinoid Receptor Agonist MDMB-CHMICA

Clinical Toxicology
MedicineToxicology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy